ReviewActa parasitologica2026
The Fight is not Over: Sustained Vigilance Against Schistosomiasis Needing in China.
Review in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
China has achieved remarkable progress toward eliminating schistosomiasis, yet potential risks persist due to residual snail habitats, animal reservoirs, and uneven surveillance coverage. This paper synthesizes current surveillance frameworks and recent literature to identify key challenges and propose actionable directions for sustaining elimination achievements. It emphasizes the need to distinguish serological evidence of past exposure from active infection when interpreting surveillance results. To consolidate elimination outcomes, we recommend a phased, evidence-based strategy: (1) strengthen integrated human–animal–environment surveillance systems, (2) enhance data sharing and cross-sectoral coordination under the One Health framework, and (3) develop long-term mechanisms for resource allocation and emergency response in re-emergence areas. These recommendations aim to guide policy refinement and prioritize resource investment for sustainable schistosomiasis control in the post-elimination era.
Indexed as
Identifiers
41712062What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.